Bisnow Content Partner:

Bisnow Media
Sponsored Content

5 Reasons To Attend Bisnow’s New Jersey Life Sciences And Healthcare Event

New Jersey is home to some of the largest life sciences campuses on the East Coast. On June 12, commercial real estate professionals will have the opportunity to learn more about this dynamic market while attending a Bisnow event at one of the state’s premier research and development facilities.

The New Jersey Life Sciences and Healthcare event takes place at the Northeast Science and Technology Center, home to more than 2M SF of office and lab space in Kenilworth, New Jersey. Also known as NEST, the campus covers more than 30 acres on the former grounds of Merck’s global headquarters.

Register here for the event.

Called the “medicine chest to the world,” New Jersey has been the birthplace of major healthcare advances such as immunotherapy and the cure for hepatitis C. On June 12, CRE professionals will gather at NEST to discuss developing more of these facilities to pave the way for many of tomorrow’s medical breakthroughs.

Opening remarks will be delivered by John Saraceno Jr., co-founder and managing principal of Onyx Equities LLC, a $4B commercial property investment, management and development firm with assets in New Jersey and neighboring states. Onyx Equities’ portfolio includes the Kenilworth Life Sciences Campus, home to NEST.

Other thought leaders will participate in panels including “Executing Build-To-Suit Life Sciences Campuses” and “Repositioning Existing Big Pharma Campuses.”

Here are five reasons to register now for this event:

1. Hear Saraceno’s take on the state’s opportunities and challenges. “We have probably the most concentrated presence of large pharma in any state in the country,” he told a life sciences news site. “Where we have fallen behind is that we don't have the sort of VC and private equity, small incubator, 10K to 15K SF-type users.”

2. Network and learn from top developers, owners and decision-makers, including panel moderators Christian Roche, Langan principal; Jim Daly, CRB Group associate project director; and Andres Blohm, buildings market lead for Jacobs.

3. Learn about the budding biotech clusters in the state.

4. Identify the macroeconomic drivers that are fueling New Jersey’s life sciences and healthcare ecosystem.

5. Meet other investors, owners, developers, lenders, brokers, architects, contractors, engineers, tenants and more at this unique event.

Don’t miss this opportunity to make new contacts and learn more about life sciences and healthcare real estate trends in New Jersey. Register here.

Continue reading this story with a free account

Log in or register

More About Our Sponsor

| Bisnow Media
Sign up for more articles like this
Subscribe to Bisnow's New Jersey Newsletters
Related Stories

Taconic Partners Sheds Another NYC Life Sciences Property

Judge Dismisses Suit Alleging Alexandria Misled Investors Over Portfolio Strength

New Occupiers And More VC Money Fuel UK Life Sciences Rebirth

DFW's Life Sciences Sector Offers Startups The Ingredients They Need To Scale

Why DivcoWest Is Advancing A New 19-Story Lab Development In Somerville

Lab Landlords In 'Hand-To-Hand Combat' To Last To Recovery

The Pain In NYC's Biotech Market Is Hitting Harlem Hardest

A Mindful Approach To Building In Specialized Environments

Revolution Medicines Nearing Agreement For 700K SF Lease In Redwood City

Alexandria Sells Cambridge Lab Condo Units For $45M

Oncology Company Expands Footprint At Hines' Life Sciences Campus

Houston's Generation Park Lands Another $2.3B Pharma Manufacturing Investment